ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,858, issued on Aug. 25, was assigned to INVENTISBIO Co. LTD. (Shanghai).
"Pyridazinone compounds" was invented by Xing Dai (Shanghai), Yanqin Liu (Shanghai) and Yueheng Jiang (Shanghai).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, in particular, Compound 1, and compositions useful for treating or preventing diseases or disorders that are modulated by thyroid hormone receptor agonists, such as non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD)."
The patent was filed on Aug. 27, 2020, under Application No. 18/023,241.
*For further information, including images, charts and tables, please ...